Opexa Therapeutics Inc. (NASDAQ:OPXA) moved down by 18.14% and closed at $1.94 whereas overall traded volume stood at 3.03 million shares for the day. Its...(
read more)
EpiCept Corporation (NASDAQ: EPCT) on Monday announced that it received a refusal to file letter from the U.S. Food and Drug Administration (FDA) on the New Drug Application (NDA) for...(
read more)